JP2009538852A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538852A5
JP2009538852A5 JP2009512481A JP2009512481A JP2009538852A5 JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5 JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009512481 A JP2009512481 A JP 2009512481A JP 2009538852 A5 JP2009538852 A5 JP 2009538852A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
pyrido
imidazo
pyrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009512481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/004747 external-priority patent/WO2007137819A1/en
Publication of JP2009538852A publication Critical patent/JP2009538852A/ja
Publication of JP2009538852A5 publication Critical patent/JP2009538852A5/ja
Pending legal-status Critical Current

Links

JP2009512481A 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法 Pending JP2009538852A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80925106P 2006-05-30 2006-05-30
PCT/EP2007/004747 WO2007137819A1 (en) 2006-05-30 2007-05-29 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM

Publications (2)

Publication Number Publication Date
JP2009538852A JP2009538852A (ja) 2009-11-12
JP2009538852A5 true JP2009538852A5 (enExample) 2010-07-15

Family

ID=38441601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009512481A Pending JP2009538852A (ja) 2006-05-30 2007-05-29 4−アミノ−ピリド[3,2−e]ピラジン、該化合物のホスホジエステラーゼ10の阻害剤としての使用、及び該化合物の製造方法

Country Status (13)

Country Link
US (1) US20070299079A1 (enExample)
EP (1) EP2021341A1 (enExample)
JP (1) JP2009538852A (enExample)
CN (1) CN101448829A (enExample)
AR (1) AR060984A1 (enExample)
AU (1) AU2007267391A1 (enExample)
BR (1) BRPI0711857A2 (enExample)
CA (1) CA2653412A1 (enExample)
CL (1) CL2007001555A1 (enExample)
MX (1) MX2008015308A (enExample)
PE (1) PE20080266A1 (enExample)
TW (1) TW200815436A (enExample)
WO (1) WO2007137819A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
EP2225248A1 (en) * 2007-11-30 2010-09-08 Wyeth LLC Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
US20090143392A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Methods of Treating Obesity and Metabolic Disorders
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
US20100120763A1 (en) * 2008-11-07 2010-05-13 Wyeth Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
WO2011150156A2 (en) * 2010-05-26 2011-12-01 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
DE102010042833B4 (de) 2010-10-22 2018-11-08 Helmholtz-Zentrum Dresden - Rossendorf E.V. Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung
US9540379B2 (en) 2011-01-31 2017-01-10 Boehringer Ingelheim International Gmbh (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
WO2012112946A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US9056863B2 (en) * 2011-09-09 2015-06-16 H. Lundbeck A/S Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof
MX381326B (es) * 2011-10-10 2025-03-12 H Lundbeck As Derivados de 7h-imidazo[1-5-a]pirazin-8-ona como inhibidores de la fosfodiesterasa 9(pde9); y el uso de los mismos en el tratamiento de trastornos neurodegenerativos
BR112014011173A2 (pt) 2011-11-09 2017-05-09 Abbvie Deutschland carboxamidas heterocíclicas úteis como inibidores de fosfodiesterase tipo 10a
US20130116241A1 (en) 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
EP2807163B1 (en) 2012-01-26 2017-03-22 H. Lundbeck A/S Pde9 inhibitors with imidazo triazinone backbone
EA029892B1 (ru) 2012-04-25 2018-05-31 Такеда Фармасьютикал Компани Лимитед Азотсодержащее гетероциклическое соединение
WO2013192273A1 (en) 2012-06-19 2013-12-27 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP6205356B2 (ja) 2012-07-13 2017-09-27 武田薬品工業株式会社 複素環化合物
US20140045856A1 (en) * 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
US9464085B2 (en) 2012-08-17 2016-10-11 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
HK1206728A1 (en) 2012-09-17 2016-01-15 AbbVie Deutschland GmbH & Co. KG Novel inhibitor compounds of phosphodiesterase type 10a
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9790203B2 (en) 2012-11-26 2017-10-17 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
US9200005B2 (en) 2013-03-13 2015-12-01 AbbVie Deutschland GmbH & Co. KG Inhibitor compounds of phosphodiesterase type 10A
MX2015012008A (es) 2013-03-14 2016-04-15 Abbvie Deutschland Compuestos inhibidores novedosos de fosfodiesterasa tipo 10a.
EP2975031A4 (en) 2013-03-14 2017-04-19 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6411342B2 (ja) 2013-07-03 2018-10-24 武田薬品工業株式会社 アミド化合物
EP3018126A4 (en) 2013-07-03 2016-12-07 Takeda Pharmaceuticals Co HETEROCYCLIC CONNECTION
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
CN103980281B (zh) * 2014-05-27 2016-06-08 天津市斯芬克司药物研发有限公司 一种咪唑吡嗪化合物及其制备方法
CA2990521C (en) 2015-07-07 2023-10-10 H. Lundbeck A/S Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
BR112020024019A2 (pt) 2018-05-25 2021-02-23 Imara Inc. monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
KR20250108770A (ko) 2018-08-31 2025-07-15 카듀리온 파마슈티칼스, 인크. 겸상 세포 질환의 치료를 위한 pde9 억제제
WO2020065583A1 (en) 2018-09-28 2020-04-02 Takeda Pharmaceutical Company Limited Balipodect for treating or preventing autism spectrum disorders
CN114524808B (zh) * 2022-02-21 2023-10-24 深圳市儿童医院 一种吡唑衍生物及其作为pde10抑制剂的用途
CN114524806B (zh) * 2022-02-22 2024-09-03 深圳市儿童医院 一种三氮唑衍生物及其作为pde10抑制剂的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69940808D1 (de) * 1998-03-04 2009-06-10 Bristol Myers Squibb Co Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren
JPH11292878A (ja) * 1998-04-09 1999-10-26 Yamanouchi Pharmaceut Co Ltd イミダゾナフチリジン誘導体
IL149106A0 (en) * 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
US20030032579A1 (en) * 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them

Similar Documents

Publication Publication Date Title
EP3317289B1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
JP6236173B2 (ja) 脊髄性筋萎縮症を処置するための化合物
AU2016256728B2 (en) Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
US7550465B2 (en) Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
JP5658664B2 (ja) 1,2−二置換複素環式化合物
CA2866143C (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
CN115448910A (zh) 一种哒嗪类衍生物抑制剂、其制备方法和应用
JP2009538853A5 (enExample)
US20070299079A1 (en) 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
CN106008479B (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的取代嘧啶类化合物及其应用
CN108137539B (zh) 取代的苯并咪唑、它们的制备和它们作为药物的用途
CN102164604A (zh) 用作激酶调节剂的稠合杂环化合物
RS63581B1 (sr) Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju lečenja fshd
JP2020532585A (ja) インターフェロン遺伝子刺激因子調節薬としての環状ジヌクレオチド
CN105936635B (zh) 作为磷脂酰肌醇3-激酶δ抑制剂的化合物及其应用
JP2017518305A (ja) ヒストンデアセチラーゼ阻害薬及び組成物並びにそれらの使用の方法
BR112015012842B1 (pt) Compostos derivados de diazol lactama, composição farmacêutica e uso dos mesmos
AU2011258005A1 (en) Heterocyclic compounds as Janus kinase inhibitors
CN107207509A (zh) 作为沉默调节蛋白调节剂的取代的桥环脲类似物
CN106414459B (zh) 作为pde1抑制剂的六氢呋喃并吡咯
CA2935985A1 (en) Organic compounds
CN112592345B (zh) 一种三氮唑并吡嗪类化合物及其用途
TW201215607A (en) Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor
CN105985354B (zh) 嘧啶衍生物、细胞毒性剂、药物组合物及其应用
CN119487031A (zh) 色胺酮衍生物及其用途